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SUPPLEMENTARY TABLES 
Supplementary Table 1: Additional statistics with age as a covariate.  
 
  
Fig. Comparison 
p-Value 
Comparison 
p-Value 
w/o age with age w/o age with age 
1A CIS17 : MS17 0.001 0.005   
1C 
BL_1-8 : BL_>8 
BL_1-8 : FU_1-8 
BL_1-8 : FU_>8 
<0.0005 
<0.0005 
0.522 
<0.0005 
<0.0005 
0.284 
BL_>8 : FU_1-8 
BL_>8 : FU_>8 
FU_1-8 : FU_>8 
<0.0005 
<0.0005 
0.001 
<0.0005 
<0.0005 
0.001 
1D 
BL_GD- : BL_GD+ 
BL_GD- : FU_GD- 
BL_GD- : FU_GD+ 
<0.0005 
<0.0005 
0.818 
<0.0005 
<0.0005 
0.473 
BL_GD+ : FU_GD- 
BL_GD+ : FU_GD+ 
FU_GD- : FU_GD+ 
<0.0005 
<0.0005 
<0.0005 
<0.0005 
<0.0005 
<0.0005 
1E 
w/o age: r = -0.170 
with age: r = -0.156 
<0.0005 <0.0005 
  
1F  0.015 0.046 
1G 
w/o age: r = 0.092 
with age: r = 0.090 
0.008 0.011 
2B  <0.0005 <0.0005 
2C  0.036 0.029 
2D  0.035 0.034 
2E  <0.0005 <0.0005 
3B  0.002 0.002 
3C w/o age: r = 0.223 
with age: r = 0.219 
<0.0005 <0.0005 
3D 
high : moderate 
high : basic 
high : no DMT 
<0.0005 
<0.0005 
<0.0005 
<0.0005 
<0.0005 
<0.0005 
moderate : basic 
moderate : no DMT 
basic : no DMT 
0.179 
0.102 
0.914 
0.259 
0.316 
1.000 
3E 
high : moderate 
high : basic 
high : no DMT 
0.4 
0.001 
0.001 
0.930 
0.008 
0.011 
moderate : basic 
moderate : no DMT 
basic : no DMT 
0.450 
0.163 
1.000 
0.461 
0.393 
1.000 
4B 
@BL 
@FU2 
@FU4 
<0.0005 
0.007 
0.128 
<0.0005 
<0.0005 
0.092 
 
  
4C 
[top] w/o age: r = 0·179 
with age: r = 0·176 
<0.0005 <0.0005 
[bottom] w/o age: r = 0.133 
with age: r = 0.152 
0.001 <0.0005 
4D 
[FU2] escalation : no switch 
escalation : de-escalation 
no switch : de-escalation 
0.001 
0.026 
0.966 
<0.0005 
0.022 
1.000 
 
  
4E 
@BL 
@FU2 
@FU4 
0.035 
0.025 
0.204 
0.040 
0.030 
0.183 
 
  
w/o age: age was not considered as a covariate; with age: statistical analysis was performed by considering age as a covariate; CIS17: clinically 
isolated syndrome [2017]; MS17: relapsing remitting multiple sclerosis [2017]; BL: baseline; FU: two-year follow-up; sNfL: serum 
neurofilament light chain; 1-8: 1-8 T2 lesions observed in the MRI scan; >8: more than 8 T2 lesions in the MRI; GD+: gadolinium enhancing 
lesions in the MRI scan; no DMT, basic, moderate, high: different treatment groups. P-values were obtained by analysing the data using the 
Mann-Whitney-U-Test, Kruskal-Wallis-Test, mixed linear models, two-way mixed ANOVA and one-way ANOVAs. Bonferroni-adjustment or 
Tukey’s post-hoc test was applied to correct for multiple comparison. Correlation analyses were performed by Spearman’s Rank Correlation and 
partial non-parametric correlations for covariates. 
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Supplementary Table 2: Baseline data of reclassified CIS[2017] patients and dropouts.  
Variable Dropouts Reclassified p-Value 
n 111 258  
 Median (IQR)  
Age (years) 33 (25-44) 33 (26-41) 0.481a 
Disease duration (months) 2 (1-3) 2 (1-2) 0.411a 
  n (%) p-Value 
Sex 
male 37 (33.3%) 76 (29.5%) 
0.459b 
female 74 (66.7%) 182 (70.5%) 
T2-lesion count 
1-8  34 (30.6%) 76 (29.8%) 
0.874b 
> 8  77 (69.4%) 179 (70.2%) 
IQR: interquartile range; CIS: clinically isolated syndrome; sNfL: serum neurofilament light chain; Mann-Whitney-U tests (a) were conducted to 
compare group differences. Distributions were compared using a chi-square tests of homogeneity (b).  
 
Supplementary Table 3: Additional support vector machine (SVM) analyses: OCBs or Gd+ lesions were 
analyzed without sNfL and with different sNfL percentiles. 
sNfL 
percentile 
number of cases 
(total n = 258) 
sNfL 
cutoff 
(pg/ml) 
% sensitivity 
[95% CI] 
% specificity 
[95% CI] 
% accuracy 
[95% CI] 
% PPV % NPV 
-  - 
71.9 
[62.3, 80.5] 
75·9 
[64.9, 84.4] 
79·4 
[68.4, 88.6] 
48.9 88.4 
50th 136 10.1 
66.2 
[57.4, 74.8] 
68·3 
[59.2, 77.2] 
72·7 
[61.5, 82.7] 
51.8 81.3 
60th 114 12.0 
69.2 
[60.2, 78.3] 
71·3 
[62.5, 82.1] 
75·6 
[64.7, 86.1] 
48.7 91.4 
70th 85 14.8 
72·2 
[63.5, 81.1] 
74·6 
[65.7, 83.9] 
77·2 
[66.5, 88.5] 
50.2 91.3 
80th 57 20.0 
75·1 
[64.8, 84.7] 
72·4 
[61.8, 81.2] 
78·2 
[67.8, 87.5] 
46.8 90.2 
Specificity (%) =    TN/(TN+FP)  * 100 
Sensitivity (%) =    TP/(TP+FN)  * 100 
Accuracy (%) =     (TP+TN)/T  * 100 
PPV = TP/(TP+FP) *100 
NPV = TN/(TN+FN) *100 
 
The entities in the above equations are: (TN (true negatives), TP (true positives), FN (false negatives), FP (false positives), PPV (positive predictive 
value), NPV (negative predictive value)), and T is the total number of data under test. CI: confidence interval, OCB: oligoclonal bands; Gd+ lesions: 
gadolinium enhancing MRI lesions; sNfL: serum neurofilament light chain. 
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SUPPLEMENTARY FIGURES 
 
Supplementary Figure 1. Relation between age and sNfL values. A) In our young cohort, no correlation was 
observed between sNfL and age (r = -0.044, p = 0.211). Correlation was determined by Spearman's rank correlation 
coefficient and is plotted with the 95% confidence interval. B) Age distribution in our cohort. Dotted line marks 
median age (32 years). 
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Supplementary Figure 2. Relation between EDSS and ring-enhancing lesions and sNfL. A) Significant weak 
correlation between sNfL levels and EDSS values (r = 0.130, p < 0.0005). Correlation was determined by 
Spearman's rank correlation coefficient. B) sNfL levels in patients with (n = 83) and without ring-enhancing 
gadolinium lesions (n = 1335, p < 0.0005, η² = 0.18). Group differences were analysed by Mann-Whitney-U-Test.  
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Supplementary Material and Methods 
 
Receiver operation characteristic (ROC) and support vector machine (SVM) analyses 
A classifier is a parameter with a suitable optimal threshold that is used in a classification algorithm. In this study we 
applied binary classification algorithms (i.e. testing the classification between the two groups termed "RRMS" and 
"CIS"). The performance of a classifier is evaluated by three main metrics, namely specificity, sensitivity and 
accuracy. Specificity indicates the ability of a classifier to detect negative cases. Sensitivity represents the ability of a 
classifier to detect the positive cases. Accuracy represents the overall performance of a classifier. It indicates the 
percentage of correctly classified positive and negative cases among the total number of cases.  
Specificity (%) =    TN/(TN+FP) * 100 
Sensitivity (%) =    TP/(TP+FN) * 100 
Accuracy (%) =     (TP+TN)/T * 100 
PPV = TP/(TP+FP) *100 
NPV = TN/(TN+FN) *100 
The entities in the above equations are: TN (true negatives), TP (true positives), FN (false negatives), FP (false 
positives), PPV (positive predictive value), NPV (negative predictive value); T is the total number of data under test. 
Receiver operating characteristic (ROC) analysis was used as a linear classifier to determine the three parameters 
mentioned above. 
We have used the support vector machine (SVM) analysis
1-3
 which is a non-linear classifier in addition to validate 
the linear classification results. For the SVM analysis, the algorithm looked for an optimally separating threshold 
between the two data sets by maximising the margin between classes' closest points. The general notion on SVM 
classifiers would favor the larger class. In general, the majority class will have a high accuracy in prediction 
(sensitivity if the positive class is the majority and specificity if the negative class is the majority) and the minority 
class will have a low accuracy. These procedures are not useful for our applications here in this study. A main 
challenge in the class-imbalanced classification is to develop a classifier that can provide good accuracy for the 
minority class prediction
4,5
. A class-imbalanced classifier typically modifies a standard classifier by a correction 
strategy or by incorporating a new strategy in the training phase to account for differential class sizes. Therefore, we 
used the SVM-based correction classifier which is a SVM threshold adjustment (SVM-THR)
6
. To have robust 
threshold adjustment, we used the 10-fold cross validation approach for defining the threshold for each of the 
estimation. The open source machine learning library LIBSVM
7
 was used as a toolbox. Specially, a composite risk 
score consisting of the factors presence or absence of Gd+ lesions and presence of 1-8 T2 lesions or more was 
calculated. Next, we added sNfL concentrations in the risk score and tested the prediction of EDSS and MSFC at 
two-year follow-up. In another approach, we tested the CIS[2010] patients and classified them according to 2017 
McDonald criteria based on the information of the further variables (i.e. OCBs and Gd+ lesions, defined as response 
variable). We then added sNfL (>90
th
 percentile) as an additional variable and repeated the SVM analysis for testing 
the classification. 
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